世界の骨・ミネラル代謝異常治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bone and Mineral Metabolism Disorders Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0938 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、骨・ミネラル代謝異常治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビスホスホネート、エストロゲン、リン吸着剤、非カルシウム、非金属ベースバインダー、金属ベースバインダー、マグネシウムベースバインダー、ビタミンD類似体・サプリメント、カルシウム模倣剤、カルシウム・マグネシウムサプリメント）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・骨・ミネラル代謝異常治療の市場動向 ・企業の競争状況、市場シェア ・骨・ミネラル代謝異常治療の種類別市場規模（ビスホスホネート、エストロゲン、リン吸着剤、非カルシウム、非金属ベースバインダー、金属ベースバインダー、マグネシウムベースバインダー、ビタミンD類似体・サプリメント、カルシウム模倣剤、カルシウム・マグネシウムサプリメント） ・骨・ミネラル代謝異常治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア） ・骨・ミネラル代謝異常治療の北米市場規模2016-2027（アメリカ、カナダ） ・骨・ミネラル代謝異常治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・骨・ミネラル代謝異常治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・骨・ミネラル代謝異常治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・骨・ミネラル代謝異常治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、F. Hoffmann-La Roche、Novartis、Warner Chilcott、Sanofi、AbbVie、Amgen） ・結論

Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone remodelling process. Bone functions as storehouse of calcium, from which calcium is continuously withdrawn or stored as a part of homeostasis. Bone mineral metabolism is refers to the maintenance of sufficient concentration of inorganic ions in blood serum irrespective of muscle tissue metabolic activities. Hormones such as parathormone and calcitonin plays vital role in controlling the muscle metabolic activities, these hormones are regulated by neuroendocrine system and produced by parathyroid and thyroid glands in the neck. Malfunction of these glands result in to metabolic in equilibrium and crates the problems of bone mineral metabolism. Bone and mineral density metabolic disorders are abnormalities of bones, caused by calcium, phosphorous, magnesium and vitamin D aberrations leading to several reversible clinical disorders. These disorders are generally treatable if the underlining cause is addressed with corrective treatment methods. These disorders are caused due to genetic or metabolic malfunctions in the body.
Global bone and mineral metabolism disorders treatment market is undergoing market changes due to the higher competition among local and multinational players and this in turn helped to make treatment cost more economical. With the availability of wide variety of products in various forms and strengths in the bone and mineral metabolism disorders treatment market is expected to change the market dynamics over a given period of forecast. By disease type, sub segment such as osteoporosis and rickets in the global bone and mineral metabolism disorders treatment market are expected to grow in positive traction owing to increased prevalence of the diseases among the post-menopausal women and children in the various regions.

Market Analysis and Insights: Global Bone and Mineral Metabolism Disorders Treatment Market
The global Bone and Mineral Metabolism Disorders Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bone and Mineral Metabolism Disorders Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bone and Mineral Metabolism Disorders Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bone and Mineral Metabolism Disorders Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bone and Mineral Metabolism Disorders Treatment market.

Global Bone and Mineral Metabolism Disorders Treatment Scope and Market Size
Bone and Mineral Metabolism Disorders Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bone and Mineral Metabolism Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bisphosphonates
Estrogens
Phosphate Binders
Non-Calcium, Non-Metal-Based Binder
Metal-Based Binders
Magnesium-Based Binders
Vitamin D Analogs and Supplements
Calcimimetic Agents
Calcium and Magnesium Supplements

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
F. Hoffmann-La Roche
Novartis
Warner Chilcott
Sanofi
AbbVie
Amgen

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bone and Mineral Metabolism Disorders Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bisphosphonates
1.2.3 Estrogens
1.2.4 Phosphate Binders
1.2.5 Non-Calcium, Non-Metal-Based Binder
1.2.6 Metal-Based Binders
1.2.7 Magnesium-Based Binders
1.2.8 Vitamin D Analogs and Supplements
1.2.9 Calcimimetic Agents
1.2.10 Calcium and Magnesium Supplements
1.3 Market by Application
1.3.1 Global Bone and Mineral Metabolism Disorders Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bone and Mineral Metabolism Disorders Treatment Market Perspective (2016-2027)
2.2 Bone and Mineral Metabolism Disorders Treatment Growth Trends by Regions
2.2.1 Bone and Mineral Metabolism Disorders Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bone and Mineral Metabolism Disorders Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Bone and Mineral Metabolism Disorders Treatment Industry Dynamic
2.3.1 Bone and Mineral Metabolism Disorders Treatment Market Trends
2.3.2 Bone and Mineral Metabolism Disorders Treatment Market Drivers
2.3.3 Bone and Mineral Metabolism Disorders Treatment Market Challenges
2.3.4 Bone and Mineral Metabolism Disorders Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bone and Mineral Metabolism Disorders Treatment Players by Revenue
3.1.1 Global Top Bone and Mineral Metabolism Disorders Treatment Players by Revenue (2016-2021)
3.1.2 Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Bone and Mineral Metabolism Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bone and Mineral Metabolism Disorders Treatment Revenue
3.4 Global Bone and Mineral Metabolism Disorders Treatment Market Concentration Ratio
3.4.1 Global Bone and Mineral Metabolism Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bone and Mineral Metabolism Disorders Treatment Revenue in 2020
3.5 Bone and Mineral Metabolism Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Bone and Mineral Metabolism Disorders Treatment Product Solution and Service
3.7 Date of Enter into Bone and Mineral Metabolism Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bone and Mineral Metabolism Disorders Treatment Breakdown Data by Type
4.1 Global Bone and Mineral Metabolism Disorders Treatment Historic Market Size by Type (2016-2021)
4.2 Global Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Type (2022-2027)

5 Bone and Mineral Metabolism Disorders Treatment Breakdown Data by Application
5.1 Global Bone and Mineral Metabolism Disorders Treatment Historic Market Size by Application (2016-2021)
5.2 Global Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bone and Mineral Metabolism Disorders Treatment Market Size (2016-2027)
6.2 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Type
6.2.1 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2021)
6.2.2 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2022-2027)
6.2.3 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2027)
6.3 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Application
6.3.1 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2021)
6.3.2 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2022-2027)
6.3.3 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2027)
6.4 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Country
6.4.1 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2016-2021)
6.4.2 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Bone and Mineral Metabolism Disorders Treatment Market Size (2016-2027)
7.2 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Type
7.2.1 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2021)
7.2.2 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2022-2027)
7.2.3 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2027)
7.3 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Application
7.3.1 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2021)
7.3.2 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2022-2027)
7.3.3 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2027)
7.4 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Country
7.4.1 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2016-2021)
7.4.2 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size (2016-2027)
8.2 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Type
8.2.1 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Application
8.3.1 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Region
8.4.1 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size (2016-2027)
9.2 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Type
9.2.1 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2027)
9.3 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Application
9.3.1 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2027)
9.4 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Country
9.4.1 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size (2016-2027)
10.2 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Type
10.2.1 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Application
10.3.1 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Country
10.4.1 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Bone and Mineral Metabolism Disorders Treatment Introduction
11.1.4 Merck Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
11.1.5 Merck Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Bone and Mineral Metabolism Disorders Treatment Introduction
11.3.4 Novartis Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Warner Chilcott
11.4.1 Warner Chilcott Company Details
11.4.2 Warner Chilcott Business Overview
11.4.3 Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Introduction
11.4.4 Warner Chilcott Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
11.4.5 Warner Chilcott Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Bone and Mineral Metabolism Disorders Treatment Introduction
11.5.4 Sanofi Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Bone and Mineral Metabolism Disorders Treatment Introduction
11.6.4 AbbVie Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Bone and Mineral Metabolism Disorders Treatment Introduction
11.7.4 Amgen Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
11.7.5 Amgen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bone and Mineral Metabolism Disorders Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bisphosphonates
Table 3. Key Players of Estrogens
Table 4. Key Players of Phosphate Binders
Table 5. Key Players of Non-Calcium, Non-Metal-Based Binder
Table 6. Key Players of Metal-Based Binders
Table 7. Key Players of Magnesium-Based Binders
Table 8. Key Players of Vitamin D Analogs and Supplements
Table 9. Key Players of Calcimimetic Agents
Table 10. Key Players of Calcium and Magnesium Supplements
Table 11. Global Bone and Mineral Metabolism Disorders Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Bone and Mineral Metabolism Disorders Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Bone and Mineral Metabolism Disorders Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Regions (2016-2021)
Table 15. Global Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Regions (2022-2027)
Table 17. Bone and Mineral Metabolism Disorders Treatment Market Trends
Table 18. Bone and Mineral Metabolism Disorders Treatment Market Drivers
Table 19. Bone and Mineral Metabolism Disorders Treatment Market Challenges
Table 20. Bone and Mineral Metabolism Disorders Treatment Market Restraints
Table 21. Global Bone and Mineral Metabolism Disorders Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Players (2016-2021)
Table 23. Global Top Bone and Mineral Metabolism Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone and Mineral Metabolism Disorders Treatment as of 2020)
Table 24. Ranking of Global Top Bone and Mineral Metabolism Disorders Treatment Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Bone and Mineral Metabolism Disorders Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Bone and Mineral Metabolism Disorders Treatment Product Solution and Service
Table 28. Date of Enter into Bone and Mineral Metabolism Disorders Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share by Type (2016-2021)
Table 32. Global Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Bone and Mineral Metabolism Disorders Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share by Application (2016-2021)
Table 36. Global Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Bone and Mineral Metabolism Disorders Treatment Product
Table 71. Merck Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021) & (US$ Million)
Table 72. Merck Recent Development
Table 73. F. Hoffmann-La Roche Company Details
Table 74. F. Hoffmann-La Roche Business Overview
Table 75. F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Product
Table 76. F. Hoffmann-La Roche Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021) & (US$ Million)
Table 77. F. Hoffmann-La Roche Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Bone and Mineral Metabolism Disorders Treatment Product
Table 81. Novartis Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Warner Chilcott Company Details
Table 84. Warner Chilcott Business Overview
Table 85. Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Product
Table 86. Warner Chilcott Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021) & (US$ Million)
Table 87. Warner Chilcott Recent Development
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Bone and Mineral Metabolism Disorders Treatment Product
Table 91. Sanofi Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. AbbVie Company Details
Table 94. AbbVie Business Overview
Table 95. AbbVie Bone and Mineral Metabolism Disorders Treatment Product
Table 96. AbbVie Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021) & (US$ Million)
Table 97. AbbVie Recent Development
Table 98. Amgen Company Details
Table 99. Amgen Business Overview
Table 100. Amgen Bone and Mineral Metabolism Disorders Treatment Product
Table 101. Amgen Revenue in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021) & (US$ Million)
Table 102. Amgen Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Type: 2020 VS 2027
Figure 2. Bisphosphonates Features
Figure 3. Estrogens Features
Figure 4. Phosphate Binders Features
Figure 5. Non-Calcium, Non-Metal-Based Binder Features
Figure 6. Metal-Based Binders Features
Figure 7. Magnesium-Based Binders Features
Figure 8. Vitamin D Analogs and Supplements Features
Figure 9. Calcimimetic Agents Features
Figure 10. Calcium and Magnesium Supplements Features
Figure 11. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Application: 2020 VS 2027
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Online Pharmacies Case Studies
Figure 15. Drug Stores Case Studies
Figure 16. Bone and Mineral Metabolism Disorders Treatment Report Years Considered
Figure 17. Global Bone and Mineral Metabolism Disorders Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Bone and Mineral Metabolism Disorders Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Regions: 2020 VS 2027
Figure 20. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Regions (2022-2027)
Figure 21. Global Bone and Mineral Metabolism Disorders Treatment Market Share by Players in 2020
Figure 22. Global Top Bone and Mineral Metabolism Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone and Mineral Metabolism Disorders Treatment as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Bone and Mineral Metabolism Disorders Treatment Revenue in 2020
Figure 24. Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share by Type (2016-2021)
Figure 25. Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share by Type (2022-2027)
Figure 26. North America Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2016-2027)
Figure 28. North America Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2016-2027)
Figure 29. North America Bone and Mineral Metabolism Disorders Treatment Market Share by Country (2016-2027)
Figure 30. United States Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2016-2027)
Figure 34. Europe Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2016-2027)
Figure 35. Europe Bone and Mineral Metabolism Disorders Treatment Market Share by Country (2016-2027)
Figure 36. Germany Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Share by Region (2016-2027)
Figure 46. China Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2016-2027)
Figure 54. Latin America Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2016-2027)
Figure 55. Latin America Bone and Mineral Metabolism Disorders Treatment Market Share by Country (2016-2027)
Figure 56. Mexico Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Share by Country (2016-2027)
Figure 62. Turkey Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Bone and Mineral Metabolism Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Merck Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
Figure 68. Warner Chilcott Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
Figure 70. AbbVie Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
Figure 71. Amgen Revenue Growth Rate in Bone and Mineral Metabolism Disorders Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---